Amgen Inc. (NASDAQ: AMGN) last traded at $439.33, up 1.88% on the session. The quote above updates while this page is open; the figures below are drawn from Amgen Inc.’s own filings and are restated only when a new one is published.
Amgen Inc. trades on NASDAQ under the ticker AMGN. It is classified in the Healthcare sector, Biotech industry. Its market capitalisation is $237.52 billion.
Healthcare sectorBiotechListed on NASDAQ
Valuation measures for Amgen Inc., derived from the latest quote and its most recent SEC filing.
| Market cap | $237.52B |
|---|---|
| P/E ratio | 27.30 |
| Price / sales | 6.23 |
| Price / book | 20.32 |
| Beta | 0.48 |
Trailing-twelve-month figures tagged in Amgen Inc.'s XBRL filings with the SEC.
| Revenue (TTM) | $38.09B |
|---|---|
| Net income (TTM) | $8.74B |
| EPS (TTM) | $16.09 |
| Operating margin | 29.99% |
| Return on equity | 74.80% |
| Cash | $13.99B |
Range and volume for AMGN over the past 52 weeks.
| 52-week high | $443.20 |
|---|---|
| 52-week low | $269.77 |
| Volume | 1.88M |
| Average volume | 2.69M |
| Previous close | $431.21 |
Dividend history for Amgen Inc. over the trailing twelve months.
| Dividend yield | 2.23% |
|---|---|
| Dividend per share (TTM) | $9.80 |
| Payout ratio | 60.91% |
Other Healthcare companies tracked on FurlPay Markets.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.